Digestive & Intestinal Remedies (Pharmacies) - Saudi Arabia

  • Saudi Arabia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$57.31m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.08%, resulting in a market volume of US$57.54m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.53 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Saudi Arabia is experiencing significant growth and development.

Customer preferences:
Customers in Saudi Arabia are increasingly seeking digestive and intestinal remedies from pharmacies. This can be attributed to several factors, including the growing awareness of digestive health issues and the convenience of purchasing remedies from pharmacies. Additionally, customers in Saudi Arabia tend to trust and rely on the advice of pharmacists, making pharmacies a preferred destination for digestive and intestinal remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Saudi Arabia is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of traditional pharmaceutical products and are opting for natural alternatives. This trend is driven by a growing interest in holistic health and wellness, as well as a preference for products that are perceived as more sustainable and environmentally friendly. Another trend in the market is the rise of online sales of digestive and intestinal remedies. With the increasing popularity of e-commerce in Saudi Arabia, customers are now able to conveniently purchase these products online and have them delivered to their doorstep. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wide range of products from different brands.

Local special circumstances:
Saudi Arabia has a high prevalence of digestive health issues, such as indigestion, acid reflux, and irritable bowel syndrome. This can be attributed to factors such as dietary habits, stress, and sedentary lifestyles. As a result, there is a strong demand for digestive and intestinal remedies in the market. The local special circumstances in Saudi Arabia also include cultural and religious factors, which influence dietary preferences and may contribute to digestive health issues.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies market in Saudi Arabia is also influenced by several macroeconomic factors. The country has a rapidly growing population, which provides a large customer base for these products. Additionally, Saudi Arabia has a high per capita income and a strong healthcare system, which enables customers to afford and access these remedies. Furthermore, the government's focus on healthcare and wellness initiatives, as well as the increasing investment in the pharmaceutical sector, contribute to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Saudi Arabia is developing due to customer preferences for convenient access to remedies, the increasing demand for natural and herbal products, the rise of online sales, the high prevalence of digestive health issues, and the underlying macroeconomic factors such as population growth, per capita income, and government initiatives.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)